Optical Coherence Tomography as an Adjunct During Carotid Artery Stenting for Carotid Atherosclerotic Disease

Christopher R Pasarikovski1, Joel Ramjist2, Leodante da Costa3

  • 1Division of Neurosurgery, Department of Surgery, University of Toronto, 399 Bathurst St., WW 4‑427, M5T 2S8, Toronto, ON, Canada. cpasarikovski2015@meds.uwo.ca.

Insights

Endovascular optical coherence tomography (OCT) safely identifies issues during carotid artery stenting (CAS), revealing plaque morphology and stent interactions. This imaging may guide future antithrombotic strategies to reduce stroke risk.

Area of Science:

  • Cardiovascular Imaging
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Carotid artery stenting (CAS) reduces stroke risk in symptomatic stenosis but carries periprocedural stroke risks.
  • Comparison with carotid endarterectomy shows higher stroke risk with CAS.
  • Need for improved intraprocedural monitoring during CAS.

Purpose of the Study:

  • To report the use of endovascular optical coherence tomography (OCT) during CAS.
  • To identify stent malapposition, plaque prolapse, and thrombus using OCT.
  • To assess OCT's role in preventing periprocedural stroke.

Main Methods:

  • Endovascular OCT imaging was approved and performed in patients undergoing CAS.
  • Images acquired before and after stenting.
  • Proximal balloon occlusion and saline flush used for clear luminal imaging.

Main Results:

  • Seven patients underwent OCT imaging without complications.
  • OCT revealed intraluminal thrombi, fibrous cap dissections, and thin-cap fibroatheromas.
  • Plaque herniation, thrombus, and poor stent apposition were visualized.

Conclusions:

  • Peri-procedural OCT imaging is safe and effective during CAS.
  • OCT provides valuable insights into plaque morphology and stent-vessel interactions.
  • Findings suggest re-evaluation of perioperative anticoagulation and potential role of OCT in guiding CAS and antithrombotic therapy.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
922
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
335
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
391
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
223
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
360
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
280